Humoral and cellular immunogenicity and safety following a booster dose of a tetravalent dengue vaccine 5+ years after completion of the primary series in Singapore

2021-03-25 11:34:03 UTC 0 Comments

Our approach developed for gating automation of cytometry data was highlighted by a new publication in Human Vaccines & Immunotherapeutics. For this study, entitled "Humoral and cellular immunogenicity and safety following a booster dose of a tetravalent dengue vaccine 5+ years after completion of the primary series in Singapore: 2-year follow-up of a randomized phase II, placebo-controlled trial", our approach was used to automate the characterization of specific polyfunctional T-cells (cell-mediated immunity) in response to a vaccine boost.

Congratulations to Dr Anke Pagnon and its team for this great work.

New Comment